HOME >> MEDICINE >> NEWS
NIAID Ebola vaccine enters human trial

quency.

On November 17, 2003, the World Health Organization reported 11 cases of Ebola hemorrhagic fever in the Republic of the Congo. Dr. Nabel notes, "The current Ebola outbreak in the Congo provides a stark reminder of the need to rapidly develop vaccines against such perilous infections. A few years ago, we did not imagine that our vaccine would enter human trials so quickly, but the re-emergence of such viruses makes it all the more important to respond quickly. Individuals who volunteer for these vaccine trials can help us understand if our new vaccines ultimately will be effective."

Twenty-seven volunteers between the ages of 18 and 44 will participate in the study. Six people will receive a placebo injection and 21 will receive the investigational vaccine, manufactured by Vical Inc., a San Diego biotechnology company working in collaboration with the VRC. Vical has also secured a nonexclusive license from NIH to proprietary gene sequences used in the DNA Ebola vaccine. In the new trial, volunteers will receive three injections over two months and will be followed for one year. Volunteers will not be exposed to Ebola virus. Individuals interested in enrolling in the trial may visit http://www.clinicaltrials.gov or call the VRC toll-free at 1-866-833-LIFE (5433).

The candidate vaccine is synthesized using modified, inactivated genes from Ebola virus. This gives the immune system information about viral structures so that it can mount a rapid defense should the real virus ever be encountered. There is no infectious material in the vaccine, and the virus was not present during any stage of the manufacturing process, notes Barney Graham, M.D., Ph.D., director of the clinical trials unit of the VRC. "It is impossible for the vaccine to cause infection," he adds, "because it employs new technology known to safely stimulate broad immune responses."

Besides assessing the vaccine's safety, re
'"/>

Contact: Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
18-Nov-2003


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIAID Ebola vaccine enters human trial

(Date:4/1/2015)... 2015 Baby Bellies & Beyond Baby ... information on the top products and services to new ... World Records title for "Mommy Moments” - the largest ... annual Baby Bellies & Beyond Expo Orlando on Sunday, ... World Record will commence at 11:00am with actual record ...
(Date:4/1/2015)... IL, Northfield, IL, Bethesda, MD, Alexandria, VA (PRWEB) ... Society for Clinical Pathology (ASCP), the College of ... (AMP), and the American Society of Clinical Oncology ... practice guideline on the use of molecular marker ... carcinoma. This evidence-based guideline will help establish standard ...
(Date:4/1/2015)... 01, 2015 Parents of teenaged and ... blog, where the latest post discusses Teen Violence Related ... of Teen Dating Violence Awareness Month, the substance abuse ... problem to help parents identify if there may be ... might involve drugs or alcohol. , “People learn how ...
(Date:4/1/2015)... 2015 Like a mosaic slowly gaining ... understanding of the potential causes of rosacea. April has ... Rosacea Society (NRS) to educate the public on the ... now estimated to affect more than 16 million Americans. ... on rosacea through its patient-funded research grants program, awarding ...
(Date:4/1/2015)... Texas (PRWEB) April 01, 2015 ... and Distinguished Teaching Professor of the Department of ... with other doctors to review reports of blindness resulting ... cosmetic surgery . The group published their study, along ... and Reconstructive Surgery journal. , "We began to see ...
Breaking Medicine News(10 mins):Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3
(Date:4/1/2015)... According to a new market ... Plastic and Reconstructive Surgery, Oncology, Ophthalmology, Gynaecology & Urology, ... Global Forecast to 2020", published by MarketsandMarkets, the Surgical ... 2020 from $402.2 Million in 2014, at a CAGR ... Browse   7 6   ma rket ...
(Date:4/1/2015)... 1, 2015 Eli Lilly and Company (NYSE: ... quarter of 2015 on Thursday, April 23, 2015.  Lilly will ... investment community and media to further detail the company,s financial ... a.m. EDT. Investors, media, and the general public can access ... that will be posted on Lilly,s website at www.lilly.com ...
(Date:4/1/2015)... , April 1, 2015 International Isotopes ... for fiscal year ended December 31, 2014.  The Company ... in net loss, and positive cash flow for the ... Total revenue in 2014 was approximately $7.5 million compared ... increase of approximately 10%.  With the exception of the ...
Breaking Medicine Technology:Surgical Microscopes Market Worth $806.6 Million by 2020 2Surgical Microscopes Market Worth $806.6 Million by 2020 3Surgical Microscopes Market Worth $806.6 Million by 2020 4Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement 2International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7
Cached News: